Synapticure
PrivateLast Round
Series A
Nov 19, 2024
Total Funding Raised
$31M
Company Overview
Synapticure operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a Series A round in November 2024.
Synapticure is a healthtech company that provides a virtual clinical care platform to identify and treat patients' neurodegenerative diseases while providing integrated access to neurologists and behavioral health services.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Mental Health, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synapticure Comparables
Compare Synapticure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neura Health | 88% | |
| Isaac Health | 85% | |
| Neuroglee Health | 84% |
For institutional investors. Book with your work email.
Synapticure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 19, 2024 | ||||
| Seed | Feb 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Synapticure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| GV | Series A, Seed |
| B Capital Group | Series A |
| Nexus NeuroTech Ventures | Series A |
| Lifeforce Capital | Seed |
| Rock Health Capital | Series A |
| Byers Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Collaborative Care Model adheres to University of Washington AIMS Center guidelines.
- Mar 1, 2026
Partnered with Centers for Medicare & Medicaid Services for dementia care model.
For institutional investors. Book with your work email.
Synapticure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synapticure's valuation, stock price, and market status.
Is Synapticure a public or private company?
Synapticure is a private company.
What is the current stock price of Synapticure?
Synapticure is a private company, so its shares have no public market price. Caplight tracks Synapticure's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synapticure worth (valuation)?
Valuation information for Synapticure is not publicly available.
Can I buy Synapticure stock?
Synapticure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synapticure's last funding round?
Synapticure's most recent funding round was Series A on November 19, 2024.
Who are the main investors in Synapticure?
Key investors in Synapticure include GV, B Capital Group.
Will Synapticure IPO soon?
No public IPO plans have been announced for Synapticure.
How can I track Synapticure secondary market activity?
Caplight tracks bids, offers, and trades in Synapticure's shares on secondary markets.